Avanos Medical (AVNS) Return on Capital Employed (2014 - 2026)
Avanos Medical recorded quarterly Return on Capital Employed of 6.77% in Q1 2026, little changed quarter-over-quarter from 6.8% in Q4 2025, and up 3246.0% year-over-year from 0.2% in Q1 2025.
Avanos Medical's Return on Capital Employed history runs 13 years deep, the most recent figure standing at 6.77% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 3246.0% year-over-year to 6.77%; the TTM figure through Mar 2026 stood at 6.77% (up 3246.0% YoY), while the FY2025 annual figure was 6.49%, up 2502.0% from the prior year.
- Return on Capital Employed came in at 6.77% for Q1 2026 at Avanos Medical, roughly flat from 6.8% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 3.03% in Q4 2022 to a low of 53.3% in Q3 2025.
- A 5-year average of 10.39% and a median of 0.28% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed slumped 5562 bps in 2025 and soared 3246 bps in 2026, its largest moves.
- Avanos Medical's Return on Capital Employed stood at 3.03% in 2022, then tumbled by 91 bps to 0.28% in 2023, then tumbled by 11320 bps to 31.97% in 2024, then surged by 79 bps to 6.8% in 2025, then rose by 0 bps to 6.77% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 6.77%, 6.8%, and 53.3% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | -6.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.77% |
| Dec 31, 2025 | -6.80% |
| Sep 30, 2025 | -53.30% |
| Jun 30, 2025 | -50.14% |
| Mar 31, 2025 | -39.23% |
| Dec 31, 2024 | -31.97% |
| Sep 30, 2024 | 2.32% |
| Jun 30, 2024 | 1.56% |
| Mar 31, 2024 | 0.97% |
| Dec 31, 2023 | 0.28% |
| Sep 30, 2023 | 0.63% |
| Jun 30, 2023 | 1.38% |
| Mar 31, 2023 | 2.08% |
| Dec 31, 2022 | 3.03% |
| Sep 30, 2022 | 0.57% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -1.16% |
| Dec 31, 2021 | -2.65% |
| Sep 30, 2021 | -4.20% |
| Jun 30, 2021 | -4.44% |
| Mar 31, 2021 | -4.08% |
| Dec 31, 2020 | -3.09% |
| Sep 30, 2020 | -0.28% |
| Jun 30, 2020 | -1.42% |
| Mar 31, 2020 | -1.92% |
| Dec 31, 2019 | -3.50% |
| Sep 30, 2019 | -3.85% |
| Jun 30, 2019 | -2.20% |
| Mar 31, 2019 | -1.07% |
| Dec 31, 2018 | 0.03% |
| Sep 30, 2018 | 0.36% |
| Jun 30, 2018 | -0.68% |
| Mar 31, 2018 | -1.77% |
| Dec 31, 2017 | -2.42% |
| Sep 30, 2017 | -12.04% |
| Jun 30, 2017 | -10.51% |
| Mar 31, 2017 | -8.92% |
| Dec 31, 2016 | -6.09% |
| Sep 30, 2016 | 18.64% |
| Jun 30, 2016 | -8.40% |
| Mar 31, 2016 | -8.44% |
| Dec 31, 2015 | -8.04% |
| Sep 30, 2015 | -19.50% |
| Jun 30, 2015 | 4.58% |
| Mar 31, 2015 | 3.36% |
| Dec 31, 2014 | 4.43% |